Burton J. Tabaac, MD, FAHA
Associate Professor of Neurology at The University of Nevada, Reno School of Medicine
Burton J. Tabaac, MD, FAHA is an Associate Professor of Neurology at The University of Nevada, Reno School of Medicine, dedicated to the cutting-edge treatment and prevention of neurological diseases. He serves as the Section Chief of Neurology and Medical Director of Stroke affiliated with Carson Tahoe Health. Dr. Tabaac is a graduate of the fellowship program in cerebrovascular neurology at The Johns Hopkins University Hospital in Baltimore, MD (2019). After graduating from AUC School of Medicine, where he earned his MD (2014), Tabaac completed a neurology residency at Rutgers Robert Wood Johnson in New Brunswick, NJ. There, he was humbled to have been selected as a three-time recipient of The Arnold P. Gold Foundation’s Humanism and Excellence in Teaching Award (2016, 2017, and 2018). Tabaac has been honored by being inducted into the Alpha Omega Alpha Honor Medical Society. In 2021 he was awarded the prestigious accolade of fellowship affiliation with the American Heart Association.
​
Tabaac’s research interests in the psychedelics space are focused on the potential for healing traumatic brain injury and promoting rehabilitation in stroke patients. Tabaac served as a TEDx speaker in 2022 at UCLA, presenting a talk entitled, “Mental Health Meets Psychedelics.” As of 2023, Tabaac has been welcomed as a Special Advisor to the Board for The McKenna Academy of Natural Philosophy. In 2024 he was appointed as a Member of the Psychedelic Medicines Working Group for Nevada State to provide expertise and testimony relating to the therapeutic use of entheogens, with presentations to the 83rd Session of the Nevada Legislature. As of 2025 he is working as a research clinician on the PHATHOM (Psychedelic Healing: Adjunct Therapy Harnessing Opened Malleability) project under the guidance of Dr. Gül Dölen of UC Berkeley, and Dr. Steven Zeiler of Johns Hopkins, pairing psilocybin and enriched environments to promote motor recovery after stroke. ClinicalTrials.gov ID: NCT07053917
​
Websites